- Q1 2024 Vericel Corp Earnings Call TranscriptMay 08, 2024$47.69 (-3.70%)Earnings
- Q4 2023 Vericel Corp Earnings Call TranscriptFeb 29, 2024$45.68 (-4.44%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Vericel Corp Earnings Call TranscriptNov 08, 2023$35.27 (-3.40%)Earnings
- Vericel Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Vericel Corp Earnings Call TranscriptAug 02, 2023$34.63 (-1.40%)Earnings
- Q1 2023 Vericel Corp Earnings Call TranscriptMay 10, 2023$34.19 (+4.11%)Earnings
- Q4 2022 Vericel Corp Earnings Call TranscriptFeb 23, 2023$30.6 (+7.29%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Vericel Corp Earnings Call TranscriptNov 09, 2022$17.65 (-23.43%)Earnings
- Q2 2022 Vericel Corp Earnings Call TranscriptAug 03, 2022$31.73 (-0.25%)Earnings
- Q1 2022 Vericel Corp Earnings Call TranscriptMay 04, 2022$31.05 (-0.99%)Earnings
- Q4 2021 Vericel Corp Earnings Call TranscriptFeb 24, 2022$38.88 (+20.82%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Vericel Corp Earnings Call TranscriptNov 09, 2021$42.15 (-2.20%)Earnings
- Vericel Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Vericel Corp Earnings Call TranscriptAug 04, 2021$49.18 (-4.91%)Earnings
- Vericel Corp at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 13, 2021
- Vericel Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Q1 2021 Vericel Corp Earnings Call TranscriptMay 05, 2021$56.59 (-4.33%)Earnings
- Vericel Corp Annual Shareholders Meeting TranscriptApr 28, 2021
- Q4 2020 Vericel Corp Earnings Call TranscriptFeb 24, 2021$49.45 (+4.39%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Vericel Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Vericel Corp Earnings Call TranscriptNov 05, 2020$21.73 (+2.50%)Earnings
- Vericel Corp Corporate Analyst Meeting TranscriptOct 16, 2020
- Vericel Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Vericel Corp Earnings Call TranscriptAug 05, 2020$15.92 (-5.35%)Earnings
- Vericel Corp at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q1 2020 Vericel Corp Earnings Call TranscriptMay 05, 2020$14.42 (+2.85%)Earnings
- Q4 2019 Vericel Corp Earnings Call TranscriptFeb 25, 2020$16.69 (-11.65%)Earnings
- Vericel Corp at Needham Growth Conference TranscriptJan 15, 2020
- Q3 2019 Vericel Corp Earnings Call TranscriptNov 05, 2019$18.34 (+12.86%)Earnings
- Vericel Corp at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Vericel Corp Earnings Call TranscriptAug 06, 2019$18.6 (+5.14%)Earnings
- Vericel Corp at UBS Global Healthcare Conference TranscriptMay 22, 2019
- Q1 2019 Vericel Corp Earnings Call TranscriptMay 07, 2019$17.3 (-5.98%)Earnings
Vericel Corp Corporate Analyst Meeting Transcript
Good morning, everyone, and welcome to the Vericel Analyst and Investor Day.
I'd now like to turn the call over to Nick Colangelo, President and CEO of Vericel.
Thank you, operator, and good morning, everyone. I'd like to welcome you to Vericel's 2020 Virtual Analyst and Investor Day. We're delighted to have an opportunity this morning to provide an update on the overall performance of our business and to host a discussion with key burn surgeon opinion leaders and highlight our commercial plans for NexoBrid, which is currently under FDA review.
Before I begin, I'd like to remind you that we will be making forward-looking statements during the course of our presentation today. These statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. These statements also may involve risks and uncertainties that could cause actual results to differ materially from expectations and are described more fully in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)